Avalo Therapeutics
AVTX
AVTX
52 hedge funds and large institutions have $113M invested in Avalo Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
-3
Holders Change %
-5.45%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
22
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.63M |
2 |
Two Sigma Advisers
New York
|
+$897K |
3 |
Two Sigma Investments
New York
|
+$755K |
4 |
Geode Capital Management
Boston,
Massachusetts
|
+$610K |
5 |
BlackRock
New York
|
+$564K |